CRISPR-Cas technologies in neurodegenerative disorders: mechanistic insights, therapeutic potential, and translational challenges. - Yashooa RK; Nabi AQ; Smail SW; Azeez SS; Nooh WA; Mustafa SA; Al-Farha AA; Capitanio N; Shekha MS (Frontiers in neurology, 2026)